|
NMRA Neumora Therapeutics Inc 1885522 |
| Balance Sheet |
|
Current Assets
|
348,608,000 |
|
Assets
|
352,537,000 |
|
Current Liabilities
|
31,743,000 |
|
Liabilities
|
31,798,000 |
|
Equity
|
320,739,000 |
|
Shares Out
|
160,028,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-132,596,000 |
|
Investing Cash Flow
|
28,242,000 |
| Market Analysis |
Market Cap
|
1,886,726,576 |
|
BVPS
|
2.00 |
|
PB
|
1.00 |
|
EPS
|
-1.66 |
|
PS
|
2.41 |
|
FCF
|
-104,354,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NMRA documents filed with the SEC.
NMRA Filings
Clear
